Trial Profile
To study Eculizumab clinical response in Patients With C3 Glomerulopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Sep 2019
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Membranoproliferative glomerulonephritis
- Focus Therapeutic Use
- 09 Sep 2019 New trial record